
Anne Fåne
- Research associate; Msc
- +47 22 78 23 18
Education:
2009 – 2010: Master in Biomedical Sciences (James Cook University, Australia), "Oxidative stress and inflammatory cytokines in Burkholderia pseudomallei-induced sepsis"
2005 – 2008: Bachelor in biology (University of Kristiansand, Norway)
2004 – 2005: Molecular Biology (University of Bergen, Norway)
Research interests/projects:
- Immunotherapy
- Therapeutic TCRs
- Chimeric Antigen Receptors (CAR)
- Cloning, expression, functional testing etc.
Work experience
2014 – Present: Research Engineer at Department of Cellular Therapy, Oslo University Hospital, Norway
2011 – 2013: Microbiology and Immunology Research Assistant at James Cook University, Townsville, Australia
Publications 2019
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
Blood Adv, 3 (8), 1230-1243
DOI 10.1182/bloodadvances.2018029678, PubMed 30979721
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
Oncoimmunology, 8 (4), e1565236
DOI 10.1080/2162402X.2019.1565236, PubMed 30906659
NK cells specifically TCR-dressed to kill cancer cells
EBioMedicine, 40, 106-117
DOI 10.1016/j.ebiom.2019.01.031, PubMed 30665853
Publications 2017
Human c-SRC kinase (CSK) overexpression makes T cells dummy
Cancer Immunol Immunother, 67 (4), 525-536
DOI 10.1007/s00262-017-2105-9, PubMed 29248956
Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia
Emerg Infect Dis, 23 (5)
DOI 10.3201/eid2305.151417, PubMed 28418830
A TCR-based Chimeric Antigen Receptor
Sci Rep, 7 (1), 10713
DOI 10.1038/s41598-017-11126-y, PubMed 28878363
Publications 2016
Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate
Hum Vaccin Immunother, 12 (12), 3089-3096
DOI 10.1080/21645515.2016.1222999, PubMed 27541593
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
Clin Transl Immunology, 5 (11), e109
DOI 10.1038/cti.2016.65, PubMed 27990285
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
Oncoimmunology, 5 (12), e1249090
DOI 10.1080/2162402X.2016.1249090, PubMed 28123886
Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate
PLoS One, 11 (6), e0156639
DOI 10.1371/journal.pone.0156639, PubMed 27310707
Publications 2015
Neurotropic threat characterization of Burkholderia pseudomallei strains
Emerg Infect Dis, 21 (1), 58-63
DOI 10.3201/eid2101.131570, PubMed 25530166